KRAS Inhibitor Research Tools for Oncology Drug Discovery
JKN Biochem supplies research-grade KRAS inhibitor tools and related signaling pathway compounds for oncology drug discovery, target validation, medicinal chemistry, and preclinical research programs.
Our portfolio covers KRAS G12C inhibitors, emerging KRAS G12D and pan-KRAS research compounds, KRAS degraders, SOS1/SHP2/MEK/ERK pathway modulators, and custom synthesized analogs for RAS-driven cancer research.
Why KRAS Inhibitor Tools Matter in Cancer Research
KRAS is one of the most intensively studied oncogenic drivers in solid tumor research. KRAS-mutant models are widely used in studies of non-small cell lung cancer, colorectal cancer, pancreatic cancer, and related RAS/MAPK pathway mechanisms.
With KRAS G12C inhibitors already used as clinical benchmarks and new KRAS G12D, pan-KRAS, ON-state/OFF-state, and degrader strategies emerging, researchers need reliable small-molecule tools to compare binding mechanisms, pathway inhibition, resistance models, and combination strategies.
This page helps buyers quickly compare mutation subtype, compound class, research application, purity, documentation, and supply mode before submitting an inquiry.
KRAS Research Compound Categories
JKN Biochem can support KRAS-related research inquiries across multiple compound categories. Customers may send product names, CAS numbers, structures, SMILES, target subtype, requested purity, and required quantity for availability and custom synthesis evaluation.
| Product / Category | Representative Scope | Research Application / Buyer Value |
|---|---|---|
| KRAS G12C inhibitors | Glecirasib, MK-1084, BBO-8520, Olomorasib, Sotorasib / Adagrasib analog references | Covalent inhibitor comparison, G12C pathway inhibition, oncology target validation, SAR comparison |
| KRAS G12D / G12V tools | MRTX1133 and emerging mutant-selective research compounds | KRAS mutation subtype studies, pancreatic and colorectal cancer models, medicinal chemistry projects |
| Pan-KRAS / RAS pathway compounds | Pan-KRAS inhibitors, RAS(ON) inhibitors, SOS1 / SHP2 pathway modulators | Resistance mechanism study, broad RAS pathway modulation, combination research |
| KRAS degraders and PROTAC-related tools | Pan-KRAS degrader, KRAS PROTAC research molecules, linker intermediates | Targeted protein degradation, degrader design, pathway suppression comparison |
| Downstream pathway modulators | RAF, MEK, ERK, PI3K/AKT/mTOR related compounds | Combination strategy, feedback pathway analysis, signaling cascade validation |
Featured KRAS-Related Research Compounds
The following products can be used as internal links from this application page to specific product detail pages. Please confirm stock, CAS number, purity, and batch documentation before publishing the final product list.
| Product | Synonyms | CAS No. | Purity | Recommended Positioning |
|---|---|---|---|---|
| Glecirasib | JAB-21822; KRAS G12C inhibitor 36 | 2657613-87-9 | 98% listed | KRAS G12C covalent inhibitor research; NSCLC/CRC/PDAC model studies; comparison with other G12C tools |
| MK-1084 | Calderasib; MK1084 | 2641216-67-1 | 98% listed | Selective KRAS G12C inhibitor research; oncology pathway studies; medicinal chemistry reference |
| BBO-8520 | BBO 8520 | 2893809-51-1 | 98% listed | KRAS G12C ON/OFF signaling research; RAS-RAF pathway interaction studies |
| Olomorasib | LY3537982 | To be confirmed | To be confirmed | Second-generation KRAS G12C inhibitor research; pathway comparison and SAR support |
| Pan-KRAS degrader-1 | KRAS degrader / PROTAC research tool | To be confirmed | To be confirmed | KRAS degradation mechanism research; PROTAC strategy exploration |
Quality & Documentation Support
For KRAS inhibitor research tools, buyers often need identity confirmation and batch documentation before testing. JKN Biochem can discuss COA, SDS, HPLC, NMR, MS, storage guidance, packaging information, and analytical data according to product and batch status.
Batch Documentation
COA, SDS, purity information, storage guidance, package size, and batch-related documents can be discussed before purchase.
Analytical Support
HPLC, NMR, MS, and additional analytical information may be available depending on compound and batch status.
Procurement Support
JKN Biochem can evaluate stock availability, custom synthesis feasibility, lead time, packaging, and shipment requirements.
Custom Synthesis for KRAS Analogs and Difficult-to-Source Molecules
In addition to catalog compound inquiries, JKN Biochem can evaluate custom synthesis projects for KRAS inhibitor analogs, intermediates, PROTAC-related molecules, linker intermediates, impurity reference standards, and structure-based research compounds.
Project discussions can cover route feasibility, scale-up potential, purity target, analytical method, lead time, confidentiality, and shipment requirements.
FAQ: KRAS Inhibitor Research Tools
What KRAS inhibitor research tools can JKN Biochem supply?
JKN Biochem can evaluate inquiries for KRAS G12C inhibitors, emerging KRAS G12D and pan-KRAS compounds, KRAS degraders, pathway modulators, related intermediates, and custom synthesized analogs.
Can JKN Biochem provide COA or analytical data?
COA, SDS, HPLC, NMR, MS, and related analytical data can be discussed according to product status, batch availability, and purchasing requirements.
Can you support custom synthesis of KRAS inhibitor analogs?
Yes. Customers can provide a structure, SMILES, target compound, purity target, and quantity requirement for feasibility review, quotation, and delivery planning.
Are KRAS inhibitor compounds supplied for clinical use?
No. These compounds are supplied for scientific research and chemical synthesis use only and are not intended for human, diagnostic, therapeutic, food, or veterinary use.
Request KRAS Inhibitor Research Tools
Looking for KRAS inhibitor research tools? Send your inquiry details and JKN Biochem will evaluate stock availability, custom synthesis feasibility, lead time, packaging, and quotation details.
Compound name, CAS number, structure or SMILES
Target subtype or pathway
Required purity and quantity
COA, SDS, HPLC, NMR, MS or other documentation needs
Destination country and expected delivery schedule
Company, institution, contact person and email
